Bruce R Huffer, MD
Orthopedic Surgery · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 33
- 9 carriers
- Office
- 1
Offices
1 location
Looking this up.
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
33 plans · 9 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Huffer’s office at (408) 297-2833 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
33 of 33 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence G46464 · Current
Licensed to practise in California · since 1981 · expires 2027-06-30 · University of Connecticut School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Surgery centers they own
- Forest Surgery Center LPAmbulatory Surgery Center · San Jose, CAOwner · accredited by JCAccreditation Renewed1 inspection, 1 with deficiencies · last 2012-09-18: Requirements Met
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$67,936
Medicare paid this office $67,936 for 151 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 60 | $9,869 | $112 |
| Short return visit (20+ min) | 48 | $7,642 | $80 |
| New patient visit (45+ min) | 54 | $7,630 | $141 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 15 | $6,494 | None |
| Aspiration and/or injection of fluid from large joint | 38 | $4,804 | $53 |
See all 7 services
| Return visit (30+ min) | 60 | $9,869 | $112 |
| Short return visit (20+ min) | 48 | $7,642 | $80 |
| New patient visit (45+ min) | 54 | $7,630 | $141 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 15 | $6,494 | None |
| Aspiration and/or injection of fluid from large joint | 38 | $4,804 | $53 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 18 | $2,938 | $155 |
| Injection, methylprednisolone acetate, 80 mg | 14 | $183 | None |
Procedures Medicare counted
| Hip replacement | 1-10 | None |
| Knee replacement | 1-10 | None |
| Lower limb (leg) arthroscopy (minimally invasive joint repair) | 1-10 | None |
Who their Medicare patients are
151 Original Medicare patients in 2024. Average age 77 · Women 70% · Also on Medicaid 70% · Health risk score 1.60. Above the middle of the specialty; the typical orthopedic surgery clinician is at 1.13.
Conditions among them: High blood pressure 75% · Diabetes 40% · Chronic kidney disease 28% · Coronary heart disease 25% · Heart failure 19% · Dementia 19% · Depression 17% · Atrial fibrillation 16% · COPD 12% · Stroke 11% · Cancer 7%.
The office billed $132,398, Medicare allowed $89,716 and paid $67,936; for 622 services of 27 kinds; $6,680 of it was for drugs given in the office and $61,256 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 151 | 622 | 77 | 1.60 | $132,398 | $67,936 |
| 2023 | 175 | 797 | 75 | 1.23 | $137,210 | $71,108 |
| 2022 | 221 | 839 | 76 | 1.49 | $160,766 | $84,114 |
| 2021 | 226 | 818 | 76 | 1.41 | $157,853 | $83,763 |
| 2020 | 168 | 602 | 74 | 1.52 | $97,547 | $48,895 |
| 2019 | 268 | 1,115 | 76 | 1.60 | $181,404 | $88,457 |
| 2018 | 293 | 1,173 | 76 | 1.53 | $202,830 | $98,801 |
| 2017 | 307 | 1,304 | 75 | 1.48 | $225,845 | $111,177 |
| 2016 | 300 | 1,140 | 75 | 1.66 | $233,209 | $116,563 |
| 2015 | 333 | 1,027 | 74 | 1.48 | $238,572 | $114,614 |
| 2014 | 431 | 1,348 | 74 | 1.55 | $298,894 | $153,029 |
| 2013 | 483 | 1,461 | 74 | 1.50 | $354,022 | $174,616 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 9 services
| Return visit (30+ min) | 71 | $12,381 | $115 |
| New patient visit (45+ min) | 72 | $10,583 | $147 |
| Short return visit (20+ min) | 49 | $9,207 | $81 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 21 | $8,826 | None |
| Aspiration and/or injection of fluid from large joint | 41 | $7,326 | $56 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,657 | $156 |
| New patient visit (30+ min) | 17 | $1,623 | $95 |
| Imaging guidance for procedure, 60 minutes or less | 18 | $981 | $43 |
| Injection, methylprednisolone acetate, 80 mg | 25 | $439 | None |
2022: 10 services
| Return visit (30+ min) | 86 | $14,275 | $118 |
| New patient visit (45+ min) | 59 | $9,011 | $153 |
| Short return visit (20+ min) | 49 | $7,958 | $85 |
| Aspiration and/or injection of fluid from large joint | 50 | $6,572 | $57 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 12 | $5,638 | None |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 24 | $4,462 | $178 |
| New patient visit (30+ min) | 45 | $4,162 | $92 |
| Extended inpatient or observation hospital service, first hour | 25 | $2,057 | $82 |
| Injection, methylprednisolone acetate, 80 mg | 39 | $711 | None |
| Imaging guidance for procedure, 60 minutes or less | 12 | $625 | $45 |
2021: 10 services
| Return visit (30+ min) | 81 | $14,515 | $118 |
| Short return visit (20+ min) | 65 | $9,112 | $84 |
| New patient visit (45+ min) | 53 | $7,565 | $143 |
| Aspiration and/or injection of fluid from large joint | 54 | $5,812 | $54 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 23 | $4,394 | $183 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 11 | $4,133 | None |
| New patient visit (30+ min) | 42 | $4,011 | $96 |
| Initial nursing facility care with high level of medical decision making, per day 50 minutes or more | 14 | $2,159 | $154 |
| Extended inpatient or observation hospital service, first hour | 21 | $1,858 | $84 |
| Injection, methylprednisolone acetate, 80 mg | 36 | $678 | None |
2020: 8 services
| Return visit (30+ min) | 59 | $8,208 | $94 |
| Short return visit (20+ min) | 55 | $5,392 | $63 |
| New patient visit (45+ min) | 31 | $4,618 | $149 |
| Aspiration and/or injection of fluid from large joint | 38 | $4,131 | $51 |
| New patient visit (30+ min) | 37 | $3,406 | $92 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $1,944 | $177 |
| Long return visit (40+ min) | 11 | $1,205 | $110 |
| Injection, methylprednisolone acetate, 80 mg | 26 | $518 | None |
2019: 11 services
| Return visit (30+ min) | 104 | $14,621 | $91 |
| Short return visit (20+ min) | 91 | $11,184 | $64 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 18 | $9,740 | None |
| Aspiration and/or injection of fluid from large joint | 63 | $7,901 | $49 |
| New patient visit (45+ min) | 48 | $6,229 | $130 |
| New patient visit (30+ min) | 62 | $5,424 | $87 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 20 | $3,473 | $174 |
| Initial nursing facility care with high level of medical decision making, per day 50 minutes or more | 14 | $1,985 | $142 |
| Imaging guidance for procedure, 60 minutes or less | 15 | $912 | $46 |
| Extended inpatient or observation hospital service, first hour | 11 | $880 | $80 |
| Injection, methylprednisolone acetate, 80 mg | 45 | $784 | None |
2018: 12 services
| Return visit (30+ min) | 106 | $15,992 | $91 |
| Short return visit (20+ min) | 102 | $11,797 | $62 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 21 | $10,728 | None |
| Aspiration and/or injection of fluid from large joint | 74 | $8,719 | $49 |
| New patient visit (45+ min) | 49 | $6,870 | $140 |
| New patient visit (30+ min) | 66 | $6,015 | $91 |
| Initial nursing facility care with moderate level of medical decision making, per day at least 35 minutes | 27 | $3,023 | $112 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 15 | $2,568 | $171 |
| Long return visit (40+ min) | 13 | $1,786 | $112 |
| Extended inpatient or observation hospital service, first hour | 13 | $1,023 | $79 |
| Imaging guidance for procedure, 60 minutes or less | 16 | $931 | $47 |
| Injection, methylprednisolone acetate, 80 mg | 42 | $737 | None |
2017: 12 services
| Return visit (30+ min) | 99 | $13,860 | $87 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 27 | $12,220 | None |
| Short return visit (20+ min) | 106 | $12,208 | $60 |
| Aspiration and/or injection of fluid from large joint | 71 | $9,000 | $47 |
| New patient visit (45+ min) | 51 | $6,781 | $133 |
| Long return visit (40+ min) | 38 | $5,475 | $119 |
| New patient visit (30+ min) | 60 | $5,192 | $87 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 18 | $3,715 | $169 |
| Initial nursing facility care with moderate level of medical decision making, per day at least 35 minutes | 29 | $3,528 | $110 |
| Extended inpatient or observation hospital service, first hour | 14 | $1,084 | $77 |
| Injection, methylprednisolone acetate, 80 mg | 63 | $959 | None |
| Imaging guidance for procedure, 60 minutes or less | 19 | $774 | $39 |
2016: 12 services
| Return visit (30+ min) | 106 | $15,820 | $88 |
| Short return visit (20+ min) | 99 | $10,594 | $61 |
| New patient visit (30+ min) | 105 | $9,539 | $91 |
| Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | 19 | $8,631 | None |
| Aspiration and/or injection of fluid from large joint | 68 | $8,567 | $46 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 31 | $5,367 | $173 |
| Long return visit (40+ min) | 20 | $3,233 | $129 |
| Extended inpatient or observation hospital service, first hour | 32 | $2,619 | $79 |
| Initial nursing facility care with moderate level of medical decision making, per day at least 35 minutes | 21 | $2,488 | $113 |
| Imaging guidance for procedure, 60 minutes or less | 29 | $1,926 | $44 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $1,334 | $89 |
| Injection, methylprednisolone acetate, 80 mg | 45 | $437 | None |
2015: 11 services
| Return visit (30+ min) | 95 | $15,255 | $94 |
| New patient visit (30+ min) | 146 | $13,019 | $89 |
| Short return visit (20+ min) | 88 | $9,124 | $62 |
| Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | 17 | $7,472 | None |
| Aspiration and/or injection of fluid from large joint | 63 | $7,040 | $45 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 24 | $4,189 | $175 |
| Long return visit (40+ min) | 18 | $2,481 | $131 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 25 | $2,012 | $59 |
| Imaging guidance for procedure, 60 minutes or less | 23 | $1,480 | $45 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 12 | $1,119 | $86 |
| Injection, methylprednisolone acetate, 80 mg | 57 | $479 | None |
2014: 16 services
| Return visit (30+ min) | 134 | $19,104 | $89 |
| New patient visit (30+ min) | 177 | $15,887 | $90 |
| Treatment of broken neck of thigh bone with plate/screw implant | 12 | $13,225 | $1,102 |
| Short return visit (20+ min) | 103 | $11,361 | $63 |
| Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | 24 | $10,379 | None |
| Aspiration and/or injection of fluid from large joint | 77 | $8,949 | $46 |
| Long return visit (40+ min) | 28 | $4,561 | $120 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 45 | $3,575 | $62 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 17 | $2,996 | $176 |
| Imaging guidance for procedure, 60 minutes or less | 34 | $2,647 | $50 |
| Initial nursing facility care with moderate level of medical decision making, per day at least 35 minutes | 13 | $1,509 | $116 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $1,460 | $91 |
| Application of elbow to finger cast | 11 | $969 | $81 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 11 | $416 | $32 |
| Short return visit (20+ min) | 12 | $409 | $34 |
| Injection, methylprednisolone acetate, 80 mg | 65 | $405 | None |
2013: 18 services
| Return visit (30+ min) | 117 | $17,025 | $89 |
| Treatment of broken neck of thigh bone with plate/screw implant | 15 | $16,273 | $1,085 |
| New patient visit (30+ min) | 170 | $15,717 | $92 |
| Short return visit (20+ min) | 153 | $15,531 | $63 |
| Treatment of upper end of broken thigh bone with placement of stabilizing device or prosthetic replacement | 13 | $13,850 | $1,065 |
| Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | 19 | $9,543 | None |
| Aspiration and/or injection of fluid from large joint | 79 | $7,846 | $46 |
| Imaging guidance for procedure, 60 minutes or less | 51 | $3,978 | $50 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 45 | $2,745 | $56 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 15 | $2,591 | $173 |
| New patient visit (45+ min) | 13 | $1,939 | $149 |
| Long return visit (40+ min) | 12 | $1,697 | $131 |
| Initial nursing facility care with moderate level of medical decision making, per day at least 35 minutes | 13 | $1,600 | $114 |
| Application of elbow to finger cast | 12 | $1,016 | $85 |
| New patient visit (30+ min) | 11 | $718 | $65 |
| Short return visit | 30 | $593 | $18 |
| Injection, methylprednisolone acetate, 80 mg | 69 | $429 | None |
| Cast supplies, short arm cast, adult (11 years +), fiberglass | 14 | $279 | $15 |
Medicaid work
$2,374 in 2024
Medicaid paid $2,374 for 219 billed services this clinician did in 2024, up to 21 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| New patient visit (45+ min) | 100 | $1,215 |
| Return visit (30+ min) | 119 | $1,159 |
| 2024 | 219 | 2 | 21 | $2,374 |
| 2023 | 440 | 3 | 29 | $1,076 |
| 2022 | 545 | 4 | 28 | $487 |
| 2021 | 458 | 5 | 26 | $672 |
| 2020 | 219 | 5 | 20 | $243 |
| 2019 | 590 | 4 | 29 | $284 |
| 2018 | 683 | 5 | 40 | $98 |
See the largest Medicaid services in earlier years
2023
| New patient visit (45+ min) | 107 | $589 |
| Return visit (30+ min) | 253 | $292 |
| New patient visit (30+ min) | 80 | $196 |
2022
| New patient visit (30+ min) | 189 | $249 |
| Return visit (30+ min) | 263 | $195 |
| Short return visit (20+ min) | 81 | $43 |
| New patient visit (45+ min) | 12 | $0 |
2021
| New patient visit (30+ min) | 143 | $253 |
| Short return visit (20+ min) | 121 | $175 |
| Return visit (30+ min) | 149 | $160 |
| New patient visit (45+ min) | 15 | $59 |
| Fluoroscopy (separate procedure), up to 1 hour physician or other qualified health care professional time | 30 | $24 |
2020
| New patient visit (30+ min) | 72 | $102 |
| Short return visit (20+ min) | 106 | $82 |
| New patient visit (45+ min) | 13 | $59 |
| Fluoroscopy (separate procedure), up to 1 hour physician or other qualified health care professional time | 14 | $0 |
| Return visit (30+ min) | 14 | $0 |
2019
| New patient visit (30+ min) | 186 | $147 |
| Return visit (30+ min) | 94 | $96 |
| Short return visit (20+ min) | 298 | $41 |
| Fluoroscopy (separate procedure), up to 1 hour physician or other qualified health care professional time | 12 | $0 |
2018
| New patient visit (30+ min) | 224 | $69 |
| Short return visit (20+ min) | 307 | $29 |
| Fluoroscopy (separate procedure), up to 1 hour physician or other qualified health care professional time | 73 | $0 |
| New patient visit (45+ min) | 15 | $0 |
| Return visit (30+ min) | 64 | $0 |
Drugs they prescribed that Part D paid
$10,947
Pharmacies billed $10,947 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 3% of their Part D prescriptions (30 of 982) in 2024. At or below the middle of the specialty; the typical orthopedic surgery clinician is at 31%.
982 generic and 0 brand-name prescriptions · $10,947 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Diclofenac | 64 | $2,999 | $47 |
| Celecoxib | 147 | $2,633 | $18 |
| Nabumetone | 157 | $1,535 | $10 |
| Sulindac | 124 | $1,453 | $12 |
| Gabapentin | 101 | $601 | $6 |
See all 13 drugs
| Diclofenac | 64 | $2,999 | $47 |
| Celecoxib | 147 | $2,633 | $18 |
| Nabumetone | 157 | $1,535 | $10 |
| Sulindac | 124 | $1,453 | $12 |
| Gabapentin | 101 | $601 | $6 |
| Baclofen | 76 | $386 | $5 |
| Meloxicam | 108 | $340 | $3 |
| Naproxen | 40 | $203 | $5 |
| Methocarbamol | 48 | $172 | $4 |
| Hydrocodone-Acetaminophen | 27 | $151 | $6 |
| Methylprednisolone | 23 | $112 | $5 |
| Cyclobenzaprine | 20 | $82 | $4 |
| Ibuprofen | 15 | $68 | $5 |
Year by year
| 2024 | 982 | 251 | 3% (30) | 0% | $10,947 |
| 2023 | 1,203 | 301 | 3% (32) | None | $24,362 |
| 2022 | 1,264 | 321 | 2% (20) | None | $24,381 |
| 2021 | 1,319 | 379 | 4% (47) | None | $21,400 |
| 2020 | 1,127 | 301 | 2% (23) | None | $20,904 |
| 2019 | 1,103 | 335 | 4% (39) | 4% | $21,040 |
| 2018 | 1,038 | 322 | 5% (54) | 6% | $28,250 |
| 2017 | 832 | 279 | 8% (69) | 5% | $25,081 |
| 2016 | 812 | 308 | 11% (88) | 9% | $28,733 |
| 2015 | 747 | 297 | 13% (97) | 13% | $40,035 |
| 2014 | 758 | 268 | 12% (87) | 22% | $55,271 |
| 2013 | 787 | 294 | 19% (146) | 24% | $44,421 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 14 drugs
| Diclofenac | 143 | $8,027 | $56 |
| Celecoxib | 149 | $4,134 | $28 |
| Sulindac | 187 | $3,770 | $20 |
| Nabumetone | 178 | $3,418 | $19 |
| Gabapentin | 131 | $1,380 | $11 |
| Baclofen | 116 | $1,189 | $10 |
| Naproxen | 50 | $574 | $11 |
| Methocarbamol | 63 | $502 | $8 |
| Meloxicam | 79 | $318 | $4 |
| Cyclobenzaprine | 28 | $242 | $9 |
| Ibuprofen | 16 | $126 | $8 |
| Hydrocodone-Acetaminophen | 21 | $118 | $6 |
| Methylprednisolone | 11 | $81 | $7 |
| Tramadol | 11 | $24 | $2 |
2022: 12 drugs
| Diclofenac | 119 | $5,665 | $48 |
| Celecoxib | 126 | $5,328 | $42 |
| Sulindac | 222 | $3,569 | $16 |
| Nabumetone | 180 | $3,095 | $17 |
| Baclofen | 184 | $2,765 | $15 |
| Gabapentin | 110 | $1,063 | $10 |
| Meloxicam | 129 | $570 | $4 |
| Naproxen | 41 | $395 | $10 |
| Methocarbamol | 63 | $374 | $6 |
| Methylprednisolone | 18 | $225 | $13 |
| Ibuprofen | 21 | $148 | $7 |
| Cyclobenzaprine | 11 | $71 | $6 |
2021: 14 drugs
| Diclofenac | 147 | $5,910 | $40 |
| Nabumetone | 193 | $3,246 | $17 |
| Celecoxib | 117 | $3,116 | $27 |
| Sulindac | 173 | $2,653 | $15 |
| Baclofen | 195 | $2,542 | $13 |
| Meloxicam | 157 | $753 | $5 |
| Naproxen | 74 | $611 | $8 |
| Gabapentin | 89 | $580 | $7 |
| Methylprednisolone | 31 | $355 | $11 |
| Methocarbamol | 41 | $315 | $8 |
| Ibuprofen | 26 | $227 | $9 |
| Hydrocodone-Acetaminophen | 23 | $137 | $6 |
| Cyclobenzaprine | 16 | $72 | $4 |
| Tramadol | 23 | $45 | $2 |
2020: 13 drugs
| Diclofenac | 183 | $9,267 | $51 |
| Nabumetone | 181 | $2,855 | $16 |
| Celecoxib | 87 | $2,337 | $27 |
| Sulindac | 118 | $1,710 | $14 |
| Baclofen | 139 | $1,152 | $8 |
| Gabapentin | 68 | $582 | $9 |
| Meloxicam | 150 | $506 | $3 |
| Naproxen | 69 | $387 | $6 |
| Cyclobenzaprine | 28 | $236 | $8 |
| Ibuprofen | 24 | $198 | $8 |
| Methylprednisolone | 17 | $155 | $9 |
| Methocarbamol | 18 | $132 | $7 |
| Tramadol | 13 | $29 | $2 |
2019: 14 drugs
| Diclofenac | 114 | $4,641 | $41 |
| Voltaren | 35 | $4,190 | $120 |
| Nabumetone | 184 | $3,467 | $19 |
| Sulindac | 114 | $1,946 | $17 |
| Celecoxib | 75 | $1,931 | $26 |
| Baclofen | 204 | $1,704 | $8 |
| Meloxicam | 156 | $549 | $4 |
| Naproxen | 59 | $455 | $8 |
| Gabapentin | 45 | $281 | $6 |
| Methylprednisolone | 15 | $236 | $16 |
| Cyclobenzaprine | 20 | $158 | $8 |
| Hydrocodone-Acetaminophen | 19 | $127 | $7 |
| Methocarbamol | 19 | $117 | $6 |
| Tramadol | 20 | $65 | $3 |
2018: 16 drugs
| Voltaren | 47 | $7,079 | $151 |
| Diclofenac | 137 | $5,248 | $38 |
| Celecoxib | 66 | $4,771 | $72 |
| Nabumetone | 162 | $2,431 | $15 |
| Oxaprozin | 13 | $2,094 | $161 |
| Sulindac | 72 | $1,058 | $15 |
| Baclofen | 132 | $863 | $7 |
| Etodolac | 15 | $799 | $53 |
| Meloxicam | 148 | $625 | $4 |
| Piroxicam | 12 | $569 | $47 |
| Gabapentin | 71 | $539 | $8 |
| Naproxen | 44 | $408 | $9 |
| Methylprednisolone | 16 | $236 | $15 |
| Hydrocodone-Acetaminophen | 26 | $230 | $9 |
| Methocarbamol | 23 | $126 | $5 |
| Tramadol | 28 | $110 | $4 |
2017: 15 drugs
| Voltaren | 33 | $4,608 | $140 |
| Celecoxib | 53 | $4,420 | $83 |
| Etodolac | 50 | $2,626 | $53 |
| Oxaprozin | 17 | $2,047 | $120 |
| Nabumetone | 134 | $2,017 | $15 |
| Sulindac | 89 | $1,536 | $17 |
| Diclofenac | 17 | $1,256 | $74 |
| Baclofen | 127 | $837 | $7 |
| Naproxen | 25 | $679 | $27 |
| Piroxicam | 12 | $440 | $37 |
| Methylprednisolone | 28 | $438 | $16 |
| Meloxicam | 121 | $413 | $3 |
| Hydrocodone-Acetaminophen | 34 | $242 | $7 |
| Gabapentin | 26 | $122 | $5 |
| Tramadol | 33 | $94 | $3 |
2016: 15 drugs
| Etodolac | 108 | $4,882 | $45 |
| Voltaren | 26 | $4,252 | $164 |
| Oxaprozin | 32 | $3,870 | $121 |
| Celecoxib | 46 | $3,479 | $76 |
| Diclofenac | 17 | $1,669 | $98 |
| Nabumetone | 96 | $1,628 | $17 |
| Baclofen | 121 | $852 | $7 |
| Meloxicam | 140 | $558 | $4 |
| Piroxicam | 12 | $557 | $46 |
| Sulindac | 34 | $398 | $12 |
| Hydrocodone-Acetaminophen | 41 | $366 | $9 |
| Methylprednisolone | 11 | $226 | $21 |
| Tramadol | 42 | $153 | $4 |
| Naproxen | 16 | $129 | $8 |
| Gabapentin | 23 | $110 | $5 |
2015: 12 drugs
| Voltaren | 55 | $8,807 | $160 |
| Etodolac | 122 | $6,232 | $51 |
| Celecoxib | 29 | $2,838 | $98 |
| Oxaprozin | 14 | $2,105 | $150 |
| Nabumetone | 81 | $1,616 | $20 |
| Baclofen | 95 | $780 | $8 |
| Meloxicam | 106 | $635 | $6 |
| Sulindac | 34 | $501 | $15 |
| Hydrocodone-Acetaminophen | 37 | $385 | $10 |
| Methylprednisolone | 16 | $303 | $19 |
| Tramadol | 58 | $177 | $3 |
| Gabapentin | 20 | $153 | $8 |
2014: 15 drugs
| Voltaren | 85 | $12,557 | $148 |
| Celebrex | 44 | $9,363 | $213 |
| Etodolac | 111 | $6,484 | $58 |
| Oxaprozin | 34 | $5,401 | $159 |
| Lidocaine | 20 | $4,349 | $217 |
| Lidoderm | 15 | $3,964 | $264 |
| Nabumetone | 83 | $2,090 | $25 |
| Meloxicam | 107 | $688 | $6 |
| Sulindac | 39 | $516 | $13 |
| Methylprednisolone | 22 | $487 | $22 |
| Baclofen | 36 | $294 | $8 |
| Tramadol | 58 | $250 | $4 |
| Gabapentin | 31 | $191 | $6 |
| Hydrocodone-Acetaminophen | 22 | $187 | $9 |
| Methocarbamol | 11 | $73 | $7 |
2013: 12 drugs
| Celebrex | 60 | $12,773 | $213 |
| Voltaren | 73 | $9,722 | $133 |
| Lidoderm | 33 | $8,626 | $261 |
| Etodolac | 125 | $3,480 | $28 |
| Nabumetone | 91 | $1,789 | $20 |
| Meloxicam | 101 | $704 | $7 |
| Tramadol | 102 | $493 | $5 |
| Hydrocodone-Acetaminophen | 43 | $266 | $6 |
| Sulindac | 19 | $234 | $12 |
| Gabapentin | 30 | $203 | $7 |
| Methocarbamol | 27 | $187 | $7 |
| Baclofen | 14 | $70 | $5 |
Money from drug and device companies
$180 in 2019
A payment is not proof that care is biased.
| Horizon Therapeutics plc | Pennsaid | $124 | 10 payments
|
| Stryker | Axsos | $29 | 1 payment
|
| Ermi | None | $20 | 1 payment
|
| Fidia Pharma USA | Hymovis | $7 | 1 payment
|
See all 13 published payments
| Horizon Therapeutics plc | Meals · 2019-12-17 | Pennsaid | $8 |
| Horizon Therapeutics plc | Meals · 2019-12-10 | Pennsaid | $15 |
| Horizon Therapeutics plc | Meals · 2019-11-26 | Pennsaid | $8 |
| Horizon Therapeutics plc | Meals · 2019-11-12 | Pennsaid | $6 |
| Ermi | Meals · 2019-10-31 | None | $20 |
| Horizon Therapeutics plc | Meals · 2019-10-15 | Pennsaid | $13 |
| Horizon Therapeutics plc | Meals · 2019-10-08 | Pennsaid | $15 |
| Horizon Therapeutics plc | Meals · 2019-07-02 | Pennsaid | $15 |
| Horizon Therapeutics plc | Meals · 2019-06-11 | Pennsaid | $18 |
| Horizon Therapeutics plc | Meals · 2019-04-30 | Pennsaid | $15 |
| Stryker | Meals · 2019-02-21 | Axsos | $29 |
| Horizon Therapeutics plc | Meals · 2019-01-16 | Vimovo | $12 |
| Fidia Pharma USA | Meals · 2019-01-11 | Hymovis | $7 |
Professional record
- NPI
- 1376581934
- Licence
- CA G46464California G46464: Current · expires 2027-06-30
- Trained
- University of Connecticut School of Medicine, 1978
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Orthopedic surgery (207X00000X)
- Mailing address
- 455 Oconnor Dr, Suite 310, San Jose, CA, 95128
- NPI first listed
- 2006-06-03
- NPI last updated
- 2007-09-19
This is when the NPI record was last certified, not a medical board exam.